Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,150 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Molecular analysis of PDGFRA and PDGFRB genes by rapid single-strand conformation polymorphism (SSCP) in patients with core-binding factor leukaemias with KIT or FLT3 mutation.
Trojani A, Ripamonti CB, Penco S, Beghini A, Nadali G, Di Bona E, Viola A, Castagnola C, Colapietro P, Grillo G, Pezzetti L, Ravelli E, Patrosso MC, Marocchi A, Cuneo A, Ferrara F, Lazzarino M, Pizzolo G, Cairoli R, Morra E. Trojani A, et al. Among authors: ferrara f. Anticancer Res. 2008 Sep-Oct;28(5A):2745-51. Anticancer Res. 2008. PMID: 19035305 Free article.
Prognostic impact of c-KIT mutations in core binding factor leukemias: an Italian retrospective study.
Cairoli R, Beghini A, Grillo G, Nadali G, Elice F, Ripamonti CB, Colapietro P, Nichelatti M, Pezzetti L, Lunghi M, Cuneo A, Viola A, Ferrara F, Lazzarino M, Rodeghiero F, Pizzolo G, Larizza L, Morra E. Cairoli R, et al. Among authors: ferrara f. Blood. 2006 May 1;107(9):3463-8. doi: 10.1182/blood-2005-09-3640. Epub 2005 Dec 29. Blood. 2006. PMID: 16384925 Free article.
Myeloablative chemotherapy followed by autologous stem cell infusion may overcome the adverse prognostic impact of FLT3 (foetal liver tyrosine kinase 3) mutations in patients with acute myeloid leukaemia and normal karyotype.
Palmieri S, Ferrara F, Leoni F, Ciolli S, Pollio F, D'Amico MR, Celentano M, Viola A, Vicari L, Izzo B, Pane F. Palmieri S, et al. Among authors: ferrara f. Hematol Oncol. 2007 Mar;25(1):1-5. doi: 10.1002/hon.794. Hematol Oncol. 2007. PMID: 17036374
An antecedent diagnosis of refractory anemia with excess blasts has no influence on mobilization of peripheral blood stem cells and hematopoietic recovery after autologous stem cell transplantation in acute myeloid leukemia.
Viola A, Falco C, D'Elia R, D'Amico MR, Vicari L, Tambaro FP, Correale P, Laudati D, Palmieri S, Ferrara F. Viola A, et al. Among authors: ferrara f. Eur J Haematol. 2007 Jan;78(1):41-7. doi: 10.1111/j.1600-0609.2006.00777.x. Epub 2006 Oct 17. Eur J Haematol. 2007. PMID: 17042770
HFE gene mutations in patients with acute leukemia.
Viola A, Pagano L, Laudati D, D'Elia R, D'Amico MR, Ammirabile M, Palmieri S, Prossomariti L, Ferrara F. Viola A, et al. Among authors: ferrara f. Leuk Lymphoma. 2006 Nov;47(11):2331-4. doi: 10.1080/10428190600821898. Leuk Lymphoma. 2006. PMID: 17107905
Clinical management of primary non-acute promyelocytic leukemia acute myeloid leukemia: Practice Guidelines by the Italian Society of Hematology, the Italian Society of Experimental Hematology, and the Italian Group for Bone Marrow Transplantation.
Morra E, Barosi G, Bosi A, Ferrara F, Locatelli F, Marchetti M, Martinelli G, Mecucci C, Vignetti M, Tura S. Morra E, et al. Among authors: ferrara f. Haematologica. 2009 Jan;94(1):102-12. doi: 10.3324/haematol.13166. Epub 2008 Nov 10. Haematologica. 2009. PMID: 19001282 Free PMC article.
Total serum tryptase: a predictive marker for KIT mutation in acute myeloid leukemia.
Cairoli R, Ripamonti CB, Beghini A, Granata S, Grillo G, Brioschi M, Nadali G, Viola A, Cattaneo C, Inropido L, Ravelli E, Bertani G, Pezzetti L, Nichelatti M, Marocchi A, Rossi G, Pizzolo G, Ferrara F, Nosari AM, Morra E. Cairoli R, et al. Among authors: ferrara f. Leuk Res. 2009 Sep;33(9):1282-4. doi: 10.1016/j.leukres.2009.03.043. Epub 2009 Apr 29. Leuk Res. 2009. PMID: 19406474
Favorable outcome in patients with acute myelogenous leukemia with the nucleophosmin gene mutation autografted after conditioning with high-dose continuous infusion of idarubicin and busulfan.
Ferrara F, Izzo T, Criscuolo C, Riccardi C, Muccioli G, Viola A, Pane F, Palmieri S. Ferrara F, et al. Biol Blood Marrow Transplant. 2010 Jul;16(7):1018-24. doi: 10.1016/j.bbmt.2010.02.011. Epub 2010 Feb 19. Biol Blood Marrow Transplant. 2010. PMID: 20172040 Free article.
1,150 results